Colored Contact Lenses 4iNLOOK Gets Over $14.8 million Investment

It is reported that the most recent round of financing in the contact lenses occurred in 2021, Moody completed more than 300 million yuan (about $44.3 million) in consecutive rounds of financing, Kilala also received two rounds of financing totaling more than 400 million yuan (about $59 million).

---

On January 10, colored contact lenses brand 4iNLOOK announced the completion of a strategic investment of more than 100 million yuan (about $14.8 million) in SinoPharm-CICC.

4iNLOOK said that this round of financing will be used to invest in the company's supply chain and brand building, while introducing more cutting-edge talent, improving the underlying technical innovation and new product development, and benchmarking against leading overseas companies to build a more professional myopia prevention and control product and service system.

According to public information, 4iNLOOK was established in November 2011 and has been deeply involved in the colored contact lenses industry. It has become one of the leading brands in the colored contact lens sector with its advanced product design and online and offline business model. Currently, 4iNLOOK has over 300 color contact lens franchise chains nationwide in China.

Contacts are one of the hottest new consumer categories after the epidemic. According to the Tmall Contact Lenses Industry Crowd Insight White Paper, contact lenses have taken up nearly fifty to sixty percent of the contact lenses market, with a compound annual growth value of nearly 50 percent for the relevant market between 2019 and 2022. It is reported that the most recent round of financing for the contact lenses industry occurred in 2021, with Moody completing more than 300 million yuan (about $44.3 million) in consecutive rounds of financing and Kilala also receiving two rounds of financing totaling more than 400 million yuan (about $59 million).

The founder of 4iNLOOK, Mr. Chen Yu, said, "We are very pleased with the investment from our strategic investor, SinoPharm-CICC. With SinoPharm-CICC's top brand advantages and industrial resources in the medical health field, the two sides can work closely together in research and development, production and sales to drive the company into a new phase of development. To build comprehensive myopia prevention and control domestic leading enterprise. 4iNLOOK will continue to cultivate the field of myopia correction and myopia prevention and control, relying on the resources of the state-owned key enterprise to build comprehensive myopia prevention and control of domestic leading enterprises."

According to official news, SinoPharm-CICC is a state-owned enterprise with rich medical industry resources as well as deep capital advantages. The company carries out investments in high-quality enterprises in the fields of innovative medical devices, innovative drug research and development, innovative medical services, and the digitalization of medicine. As for this investment, Mr. Li Ke, General Manager of SinoPharm-CICC, said, "As a leading colored contact lens company, 4iNLOOK has rich brand resources and marketing system and has a leading deployment in supply chain and new product development. SinoPharm-CICC currently has a deployment of various life and health products and service resources for consumers in China. The investment in 4iNLOOK is in line with SinoPharm-CICC's long-term development philosophy of building a product and service system with SinoPharm-CICC's characteristics and continuously meeting people's needs for a healthy and better life."